Researchers develop a deep learning framework to accelerate ultra-low-field brain MRI, achieving faster scan times and enhanced image quality. The method shows promise in making MRI more accessible and reliable, especially in settings with limited access to high-field scanners.
APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted – Biotech Investments
EQS-News: APONTIS PHARMA AG / Key word(s): 9 Month figures/Change in Forecast APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024